Association of CD19+-Targeted Chimeric Antigen Receptor (CAR) T-cell Therapy with Hypogammaglobulinemia, Infection and Mortality.
Sutherland NM, Zhou B, Zhang L, Ong MS, Hong JS, Pak A, Liu KJ, Frigault MJ, Maus MV, Hill JA, Reynolds K, Walter JE, Camargo CA Jr, Barmettler S.
Sutherland NM, et al. Among authors: hong js.
J Allergy Clin Immunol. 2024 Nov 4:S0091-6749(24)01165-5. doi: 10.1016/j.jaci.2024.10.021. Online ahead of print.
J Allergy Clin Immunol. 2024.
PMID: 39505278